Form 8-K - Current report:
SEC Accession No. 0001140361-20-003371
Filing Date
2020-02-14
Accepted
2020-02-14 16:15:32
Documents
4
Period of Report
2020-02-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nt10006928x21_8k.htm 8-K 28503
2 EXHIBIT 99.1 nt10006928x21_ex99-1.htm EX-99.1 7756
3 EXHIBIT 99.2 nt10006928x21_ex99-2.htm EX-99.2 12901
4 image00001.jpg GRAPHIC 3333
  Complete submission text file 0001140361-20-003371.txt   55261
Mailing Address 303A COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 303A COLLEGE ROAD EAST PRINCETON NJ 08540 800-208-3343
PDS Biotechnology Corp (Filer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37568 | Film No.: 20620043
SIC: 2834 Pharmaceutical Preparations